Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
68.00    2.50 (3.82%)
Bid:
66.00
Ask:
70.00
Spread: 4.00 (6.061%)
Market Cap: £53.59m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Holding(s) in Company

1 Jun 2026 15:35

RNS Number : 5216G
Hardide PLC
01 June 2026
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

 

ISIN

GB00BJJPX768

 

Issuer Name

HARDIDE PLC

 

UK or Non-UK Issuer

UK

 

2. Reason for Notification

 

An acquisition or disposal of voting rights.

 

3. Details of person subject to the notification obligation

 

Name

Maven Capital Partners UK LLP 

 

City of registered office (if applicable)

Glasgow

 

Country of registered office (if applicable)

United Kingdom

 

4. Details of the shareholder

 

Name

City of registered office

Country of registered office

Maven Renovar VCT PLC

London

England and Wales

Maven Income and Growth VCT 4 PLC

Glasgow

Scotland

Maven Income and Growth VCT PLC

London

England and Wales

 

5. Date on which the threshold was crossed or reached

 

29-May-2026

 

6. Date on which Issuer notified

 

29-May-2026

 

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.604168

0.000000

2.604168

2,052,416

Position of previous notification (if applicable)

3.872998

0.000000

3.872998

3,052,416

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

 

8A. Voting rights attached to shares

 

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BJJPX768

2,052,416

2.604168

Sub Total 8.A

2,052,416

2.604168%

 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

 

9. Information in relation to the person subject to the notification obligation

 

1.  Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

 

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional Information

 

 

12. Date of Completion

 

01-Jun-2026

 

13. Place Of Completion

 

Glasgow

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLAKDBBQBKDOAK
Date   Source Headline
1st Jun 20263:35 pmRNSHolding(s) in Company
27th May 20267:00 amRNSSignificant further order intake North America
21st May 20267:00 amRNSInterim Statement
5th May 20266:00 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSNew Order Intake and Notice of Interim Results
24th Mar 20264:30 pmRNSResult of AGM
24th Mar 20264:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAGM Trading Statement
20th Mar 20265:05 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSNotice of AGM
17th Mar 20267:00 amRNSNotice of AGM
11th Mar 202610:09 amRNSHolding(s) in Company
11th Mar 202610:09 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSFurther significant North American order intake
13th Feb 202612:03 pmRNSHolding(s) in Company
11th Feb 202611:35 amRNSDirector Dealings
10th Feb 202612:48 pmRNSGrant of Executive Share Options
3rd Feb 20267:00 amRNSSignificant New Order in North America
29th Jan 202611:17 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSAnnual results to 30 September 2025
12th Jan 20267:00 amRNSNotice of Results
1st Dec 20253:03 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSSignificant Orders from a Major New Customer
7th Nov 20258:53 amRNSHolding(s) in Company
24th Oct 20255:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSYear End Trading Update
28th May 20253:00 pmRNSDirector Dealings
27th May 20252:48 pmRNSDirector Dealings
20th May 20257:00 amRNSInterim Statement
18th Mar 20253:30 pmRNSResult of AGM
18th Mar 20257:00 amRNSAGM Trading Statement
4th Feb 20257:00 amRNSDirector Dealings
29th Jan 20257:00 amRNSAnnual results for year ended 30 September 2024
15th Jan 202510:00 amRNSNotice of Results
27th Dec 20247:00 amRNSGrant of Options and Issue of Shares
18th Dec 20247:00 amRNSNew Aerospace Supply Agreement
3rd Dec 20247:00 amRNSBoard Changes
21st Oct 20247:00 amRNSYear End Trading Update
18th Jun 20247:00 amRNSBoard Change and Appointment of Sole Broker
22nd May 20247:01 amRNSInterim Statement
22nd May 20247:00 amRNSAnnouncement of new Chief Executive Officer
8th May 20247:00 amRNSNotice of Results
1st May 202410:27 amRNSHolding(s) in Company
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.